Manufacture

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies.

How can we improve medicines for the blind and visually impaired?

Researchers create micro-feeder that eases the handling of small quantities of powder.

When following COVID-19 research, it’s hard to keep your eye on the ball...

How can we best deliver solubility-challenged small molecules to the clinic?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.